amosulalol has been researched along with Blood Pressure, High in 6 studies
amosulalol: RN given is for mono-HCl; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "To clarify the hemodynamic and endocrine mechanisms of the hypotensive effect of amosulalol, an alpha- and beta-adrenoceptor antagonist, 19 patients with essential hypertension received amosulalol (20-80 mg/day; average 48." | 7.68 | Hemodynamic and endocrine changes associated with hypotensive action of amosulalol in essential hypertension. ( Ando, K; Fujita, T; Noda, H; Ogata, E, 1992) |
| "A 42-year-old woman with pheochromocytoma received preoperatively a combined alpha- and beta-adrenoceptor blocking agent, amosulalol, exerting some inhibitory action on both receptors." | 7.68 | Failure of blood pressure control by a new combined alpha- and beta-blocking agent (amosulalol) in a patient with pheochromocytoma. ( Irisawa, C; Kawamura, S; Nakada, T; Watanabe, H; Yamaguchi, T, 1991) |
| " In our patient, both YM-09538 and bunazosin were effective in controlling severe hypertension preoperatively." | 4.77 | Periodic fluctuation of blood pressure and its management in a patient with pheochromocytoma. Case report and review of the literature. ( Ohno, M; Oishi, S; Sasaki, M; Sato, T; Umeda, T, 1988) |
| "To clarify the hemodynamic and endocrine mechanisms of the hypotensive effect of amosulalol, an alpha- and beta-adrenoceptor antagonist, 19 patients with essential hypertension received amosulalol (20-80 mg/day; average 48." | 3.68 | Hemodynamic and endocrine changes associated with hypotensive action of amosulalol in essential hypertension. ( Ando, K; Fujita, T; Noda, H; Ogata, E, 1992) |
| "A 42-year-old woman with pheochromocytoma received preoperatively a combined alpha- and beta-adrenoceptor blocking agent, amosulalol, exerting some inhibitory action on both receptors." | 3.68 | Failure of blood pressure control by a new combined alpha- and beta-blocking agent (amosulalol) in a patient with pheochromocytoma. ( Irisawa, C; Kawamura, S; Nakada, T; Watanabe, H; Yamaguchi, T, 1991) |
| "Amosulalol was approximately threefold more potent than labetalol and arotinolol in decreasing blood pressure (BP) in conscious SHR." | 1.29 | Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats. ( Honda, K; Inagaki, O; Nakagawa, C; Shibasaki, M; Sudoh, K, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inagaki, O | 1 |
| Sudoh, K | 1 |
| Shibasaki, M | 1 |
| Nakagawa, C | 1 |
| Honda, K | 1 |
| Ando, K | 1 |
| Noda, H | 1 |
| Ogata, E | 1 |
| Fujita, T | 1 |
| Inoue, Y | 1 |
| Yaga, K | 1 |
| Nishimura, M | 1 |
| Okafuji, K | 1 |
| Fujii, Y | 1 |
| Nagasaka, Y | 1 |
| Tanaka, M | 1 |
| Fujita, N | 1 |
| Kaku, K | 1 |
| Kaneko, T | 1 |
| Yamaguchi, T | 1 |
| Irisawa, C | 1 |
| Watanabe, H | 1 |
| Kawamura, S | 1 |
| Nakada, T | 1 |
| Sha, K | 1 |
| Furuya, H | 1 |
| Kuro, M | 1 |
| Kitaguchi, K | 1 |
| Yamagishi, N | 1 |
| Marunaka, S | 1 |
| Shimoyama, J | 1 |
| Okuda, T | 1 |
| Oishi, S | 1 |
| Sasaki, M | 1 |
| Ohno, M | 1 |
| Umeda, T | 1 |
| Sato, T | 1 |
1 review available for amosulalol and Blood Pressure, High
| Article | Year |
|---|---|
Periodic fluctuation of blood pressure and its management in a patient with pheochromocytoma. Case report and review of the literature.
Topics: Adrenal Gland Neoplasms; Antihypertensive Agents; Blood Pressure; Catecholamines; Ethanolamines; Hum | 1988 |
5 other studies available for amosulalol and Blood Pressure, High
| Article | Year |
|---|---|
Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antihypert | 1994 |
Hemodynamic and endocrine changes associated with hypotensive action of amosulalol in essential hypertension.
Topics: Adult; Aldosterone; Antihypertensive Agents; Blood Pressure; Cardiac Output; Ethanolamines; Female; | 1992 |
Antihypertensive and metabolic effects of long-term treatment with amosulalol in non-insulin dependent diabetics.
Topics: Adult; Aged; Antihypertensive Agents; Blood Glucose; Cholesterol, HDL; Diabetes Mellitus, Type 2; Di | 1992 |
Failure of blood pressure control by a new combined alpha- and beta-blocking agent (amosulalol) in a patient with pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Antihypertensive Agents; Ethanolamines; Female; Humans; Hypertension | 1991 |
[Effects of a new alpha- and beta-adrenoceptor blocking drug (YM-09538) on intraoperative hypertension].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Ethanolamines; Female; Heart | 1988 |